Konservierung zellfreier Nukleinsäuren

    公开(公告)号:DE202010018569U1

    公开(公告)日:2017-09-26

    申请号:DE202010018569

    申请日:2010-02-11

    Applicant: STRECK INC

    Abstract: Blutsammelröhrchen zur Stabilisierung von Nukleinsäuren innerhalb einer entnommenen Blutprobe, wobei das Blutsammelröhrchen ein Schutzmittel enthält, welches – ein Konservierungsmittel ausgewählt aus Diazolidinylharnstoff, Imidazolidinylharnstoff und einer beliebigen Kombination davon, und – einen Nukleasehemmer ausgewählt aus der Gruppe bestehend aus Diethylpyrocarbonat, Ethanol, Aurintricarbonsäure (ATA), Formamid, Vanadyl-Ribonukleosid-Komplexe, Macaloid, Ethylendiamintetraessigsäure (EDTA), Proteinase K, Heparin, Hydroxylamin-Sauerstoff-Kupfer(II)ion, Bentonit, Ammoniumsulfat, Dithiothreitol (DTT), Beta-Mercaptoethanol, Cystein, Dithioerythrit, Tris-(2-carboxyethyl)phosphen-Hydrochlorid oder ein zweiwertiges Kation wie Mg+2, Mn+2, Zn+2, Fe+2, Ca+2, Cu+2 und eine beliebige Kombination davon umfasst; wobei die Innenwand des Blutsammelröhrchens eine Polymerbeschichtung aufweist ausgewählt aus siliciumhaltigen Polymeren, Polyolefinen, Polyethylenterephthalat, fluorierten Polymeren, Polyvinylchlorid, Polystyrol und einer beliebigen Kombination davon.

    Blutsammelröhrchen
    64.
    发明专利

    公开(公告)号:DE202010018545U1

    公开(公告)日:2017-08-07

    申请号:DE202010018545

    申请日:2010-01-20

    Applicant: STRECK INC

    Abstract: Blutsammelröhrchen für nichtinvasives pränatales Screening zur Identifizierung fötaler Merkmale, enthaltend: ein Nukleinsäureschutzmittel, welches Imidazolidinylharnstoff und Ethylendiamintetraessigsäure (EDTA) enthält; wobei das Schutzmittel verhindert, dass Blutzellen (i) genomische Nukleinsäuren in eine Blutprobe freisetzen und (ii) Nukleaseaktivität erfahren, die fötale Nukleinsäure abbaut.

    Preservación de ácidos nucleicos fetales en plasma materno

    公开(公告)号:ES2617147T3

    公开(公告)日:2017-06-15

    申请号:ES10000518

    申请日:2010-01-20

    Applicant: STRECK INC

    Abstract: Un procedimiento exploratorio no invasivo prenatal para la identificación de características fetales, que comprende las etapas de: poner en contacto una muestra de sangre materna extraída, que incluye una pluralidad de células sanguíneas, con un agente protector de ácido nucleico, para evitar que las células sanguíneas (i) liberen ácidos nucleicos genómicos a la muestra de sangre y (ii) experimenten una actividad nucleasa que degrade los ácidos nucleicos fetales; aislar los ácidos nucleicos fetales de la muestra de sangre materna; y analizar los ácidos nucleicos fetales aislados para identificar una característica fetal en el que el agente protector incluye glicina e imidazolidinil urea, y ácido etilendiaminotetraacético en el que el agente protector contiene menos del 1 % en peso de formaldehído.

    IMPROVED BLOOD COLLECTION TUBE
    66.
    发明专利

    公开(公告)号:CA2538968C

    公开(公告)日:2015-03-31

    申请号:CA2538968

    申请日:2006-03-08

    Applicant: STRECK INC

    Abstract: Improvements in blood collection and testing. In one aspect, an improved method of manufacturing a blood collection tube, particularly illustrated for use in sedimentation rate testing, including providing an elongated glass tube with an open first end for receiving a venipuncture blood sample of at least 1 ml, formed with a closed end opposite the first end; and applying to a substantial portion of the receptacle a containment barrier. The improvements also pertain to resulting blood collection tubes, additives for blood collection tubes that permit reliable sedimentation test data after 8 hours from the blood draw, and methods of administering health care using the aforenoted tubes, additives or both.

    COMPOSITIONS AND METHODS FOR STABILIZING CIRCULATING TUMOR CELLS

    公开(公告)号:CA2917912A1

    公开(公告)日:2015-01-29

    申请号:CA2917912

    申请日:2014-07-22

    Applicant: STRECK INC

    Abstract: Compositions and Methods for Stabilizing Circulating Tumor Cells Methods and compositions for stabilizing a biological sample for analysis, comprising the steps of obtaining in a sample collection device a biological sample from a subject, especially blood, the biological sample including at least one circulating tumor cell from the subject. The methods may include a step of contacting the biological sample with a protective agent composition that includes a preservative agent, an optional anticoagulant, and a quenching agent to form a mixture that includes the protective agent composition and the sample.

    PRESERVATION OF FETAL NUCLEIC ACIDS IN MATERNAL PLASMA

    公开(公告)号:CA2690651A1

    公开(公告)日:2011-01-22

    申请号:CA2690651

    申请日:2010-01-21

    Applicant: STRECK INC

    Abstract: A method for preserving and processing fetal nucleic acids located within maternal plasma is disclosed, wherein a sample of maternal blood containing fetal nucleic acids is treated to reduce both cell lysis of the maternal blood cells and deoxyribonuclease (DNase) and ribonuclease (RNase) activity within the fetal nucleic acids. The treatment of the sample aids in increasing the amount of fetal nucleic acids that can be identified and tested while maintaining the structure and integrity of the fetal nucleic acids.

    SAMPLE COLLECTION CONTAINERS, PROCESSES AND COLLECTED SAMPLES

    公开(公告)号:US20230302454A1

    公开(公告)日:2023-09-28

    申请号:US18020893

    申请日:2021-08-13

    Applicant: STRECK, INC.

    CPC classification number: B01L3/5082 B01L2200/16 B01L2300/16

    Abstract: The present teachings relate to a method of making a biological sample collection container, an internally coated biological sample collection container, and uses of the same, particularly for omic analysis. A reagent (or a reagent precursor) is deposited in a liquid state at least partially along at least one side wall of the container. The reagent precursor is dried to form a dried coating having a predefined pattern and topology along at least a portion of the at least one side wall. A container thus results having a coating that includes, in a dried state, a stabilizer agent, or reaction product of a stabilizer agent and an anticoagulant, and upon collection of a sample enables stabilization of any present white blood cells, cell-free nucleic acids, extracellular vesicles, circulating tumor cells, proteins, metabolites, lipids, or any combination thereof, and preserving them in sufficient quantity and quality for omic analysis.

Patent Agency Ranking